← Back
$VRDN All transactions

Viridian Therapeutics, Inc.\DE

▲ BUY
9 / 10

Conviction

$ Value

$10.0M

Shares

454,545

Price

$22

Filed

Oct 27

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Fairmount Funds Management LLC

Title

CIK

0001802528

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-10-23

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

3,914,458

Footnotes

Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Filing Info

Accession No.

0001104659-25-102606

Form Type

4

Issuer CIK

0001590750

Fairmount Funds Management LLC's History

Date Ticker Type Value
2026-03-31 COGT C
2026-03-31 COGT $242.6M
2026-03-31 COGT C $0
2026-03-31 ZBIO $3.0M
2026-03-23 DMRA A $0
2026-01-22 APGE $133.5M
2026-01-22 COGT $127.4M
2025-12-04 CBIO $18.2M
2025-12-04 CBIO $1.8M
2025-10-23 VRDN $10.0M

Other Insiders at VRDN (90d)

No other insider activity at this issuer in the last 90 days.